Selective antagonists of A2A adenosine receptors
Details for Australian Patent Application No. 2005231440 (hide)
International Classifications
Event Publications
12 October 2006 PCT application entered the National Phase
PCT publication WO2005/097140 Priority application(s): WO2005/097140
24 March 2011 Assignment before Grant
Adenosine Therapeutics, LLC The application has been assigned to Trovis Pharmaceuticals, LLC
19 January 2012 Application Accepted
Published as AU-B-2005231440
17 May 2012 Standard Patent Sealed
16 August 2012 Assignment Registered
Trovis Pharmaceuticals, LLC The patent has been assigned to Dogwood Pharmaceuticals, Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005231443-Method and apparatus for dermatological treatment and tissue reshaping
2005231436-Use of 5,10-methylene tetrahydrofolate for the treatment of cancer
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser